Global Cannabis Use Disorder Treatment Market Research Report 2025(Status and Outlook)
Description
Report Overview
The market for Cannabis Use Disorder (CUD) treatment focuses on addressing problematic cannabis use, characterized by dependence, withdrawal symptoms, and impaired daily functioning. CUD treatments include behavioral therapies (e.g., cognitive behavioral therapy, motivational enhancement therapy) and pharmacological interventions, though FDA-approved medications specifically for CUD remain limited. The market is driven by increasing cannabis consumption globally, rising legalization, and growing awareness of CUD as a diagnosable condition. However, challenges include stigma, limited treatment accessibility, and a lack of standardized pharmacotherapy. Emerging trends involve clinical trials for novel medications (e.g., cannabinoid antagonists, GABAergic drugs) and digital therapeutics like app-based interventions. Regulatory support for research and reimbursement policies will shape future growth, particularly in North America and Europe where cannabis use and treatment demand are highest.
The global Cannabis Use Disorder Treatment market size was estimated at USD 1834.31 million in 2024, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Cannabis Use Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cannabis Use Disorder Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cannabis Use Disorder Treatment market in any manner.
Global Cannabis Use Disorder Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Alkermes
BioCorRx
Cipla Limited
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals Limited
Intas Pharmaceuticals Limited
Indivior
Mallinckrodt
Noramco
Orexo AB
Purdue Pharma
Market Segmentation (by Type)
Tobacco/Nicotine and Vaping
Alcohol
Marijuana
Synthetic Cannabinoids
Others
Market Segmentation (by Application)
Hospitals and Clinics
Rehabilitation Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabis Use Disorder Treatment Market
Overview of the regional outlook of the Cannabis Use Disorder Treatment Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Use Disorder Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabis Use Disorder Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The market for Cannabis Use Disorder (CUD) treatment focuses on addressing problematic cannabis use, characterized by dependence, withdrawal symptoms, and impaired daily functioning. CUD treatments include behavioral therapies (e.g., cognitive behavioral therapy, motivational enhancement therapy) and pharmacological interventions, though FDA-approved medications specifically for CUD remain limited. The market is driven by increasing cannabis consumption globally, rising legalization, and growing awareness of CUD as a diagnosable condition. However, challenges include stigma, limited treatment accessibility, and a lack of standardized pharmacotherapy. Emerging trends involve clinical trials for novel medications (e.g., cannabinoid antagonists, GABAergic drugs) and digital therapeutics like app-based interventions. Regulatory support for research and reimbursement policies will shape future growth, particularly in North America and Europe where cannabis use and treatment demand are highest.
The global Cannabis Use Disorder Treatment market size was estimated at USD 1834.31 million in 2024, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Cannabis Use Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cannabis Use Disorder Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cannabis Use Disorder Treatment market in any manner.
Global Cannabis Use Disorder Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Alkermes
BioCorRx
Cipla Limited
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals Limited
Intas Pharmaceuticals Limited
Indivior
Mallinckrodt
Noramco
Orexo AB
Purdue Pharma
Market Segmentation (by Type)
Tobacco/Nicotine and Vaping
Alcohol
Marijuana
Synthetic Cannabinoids
Others
Market Segmentation (by Application)
Hospitals and Clinics
Rehabilitation Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabis Use Disorder Treatment Market
Overview of the regional outlook of the Cannabis Use Disorder Treatment Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Use Disorder Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabis Use Disorder Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
151 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Cannabis Use Disorder Treatment
- 1.2 Key Market Segments
- 1.2.1 Cannabis Use Disorder Treatment Segment by Type
- 1.2.2 Cannabis Use Disorder Treatment Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Cannabis Use Disorder Treatment Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Cannabis Use Disorder Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Cannabis Use Disorder Treatment Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Cannabis Use Disorder Treatment Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Cannabis Use Disorder Treatment Product Life Cycle
- 3.3 Global Cannabis Use Disorder Treatment Sales by Manufacturers (2020-2025)
- 3.4 Global Cannabis Use Disorder Treatment Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Cannabis Use Disorder Treatment Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Cannabis Use Disorder Treatment Market Competitive Situation and Trends
- 3.8.1 Cannabis Use Disorder Treatment Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Cannabis Use Disorder Treatment Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Cannabis Use Disorder Treatment Industry Chain Analysis
- 4.1 Cannabis Use Disorder Treatment Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Cannabis Use Disorder Treatment Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Cannabis Use Disorder Treatment Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Cannabis Use Disorder Treatment Market
- 5.7 ESG Ratings of Leading Companies
- 6 Cannabis Use Disorder Treatment Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Cannabis Use Disorder Treatment Sales Market Share by Type (2020-2025)
- 6.3 Global Cannabis Use Disorder Treatment Market Size Market Share by Type (2020-2025)
- 6.4 Global Cannabis Use Disorder Treatment Price by Type (2020-2025)
- 7 Cannabis Use Disorder Treatment Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Cannabis Use Disorder Treatment Market Sales by Application (2020-2025)
- 7.3 Global Cannabis Use Disorder Treatment Market Size (M USD) by Application (2020-2025)
- 7.4 Global Cannabis Use Disorder Treatment Sales Growth Rate by Application (2020-2025)
- 8 Cannabis Use Disorder Treatment Market Sales by Region
- 8.1 Global Cannabis Use Disorder Treatment Sales by Region
- 8.1.1 Global Cannabis Use Disorder Treatment Sales by Region
- 8.1.2 Global Cannabis Use Disorder Treatment Sales Market Share by Region
- 8.2 Global Cannabis Use Disorder Treatment Market Size by Region
- 8.2.1 Global Cannabis Use Disorder Treatment Market Size by Region
- 8.2.2 Global Cannabis Use Disorder Treatment Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Cannabis Use Disorder Treatment Sales by Country
- 8.3.2 North America Cannabis Use Disorder Treatment Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Cannabis Use Disorder Treatment Sales by Country
- 8.4.2 Europe Cannabis Use Disorder Treatment Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Cannabis Use Disorder Treatment Sales by Region
- 8.5.2 Asia Pacific Cannabis Use Disorder Treatment Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Cannabis Use Disorder Treatment Sales by Country
- 8.6.2 South America Cannabis Use Disorder Treatment Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Cannabis Use Disorder Treatment Sales by Region
- 8.7.2 Middle East and Africa Cannabis Use Disorder Treatment Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Cannabis Use Disorder Treatment Market Production by Region
- 9.1 Global Production of Cannabis Use Disorder Treatment by Region(2020-2025)
- 9.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Region (2020-2025)
- 9.3 Global Cannabis Use Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Cannabis Use Disorder Treatment Production
- 9.4.1 North America Cannabis Use Disorder Treatment Production Growth Rate (2020-2025)
- 9.4.2 North America Cannabis Use Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Cannabis Use Disorder Treatment Production
- 9.5.1 Europe Cannabis Use Disorder Treatment Production Growth Rate (2020-2025)
- 9.5.2 Europe Cannabis Use Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Cannabis Use Disorder Treatment Production (2020-2025)
- 9.6.1 Japan Cannabis Use Disorder Treatment Production Growth Rate (2020-2025)
- 9.6.2 Japan Cannabis Use Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Cannabis Use Disorder Treatment Production (2020-2025)
- 9.7.1 China Cannabis Use Disorder Treatment Production Growth Rate (2020-2025)
- 9.7.2 China Cannabis Use Disorder Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 AbbVie
- 10.1.1 AbbVie Basic Information
- 10.1.2 AbbVie Cannabis Use Disorder Treatment Product Overview
- 10.1.3 AbbVie Cannabis Use Disorder Treatment Product Market Performance
- 10.1.4 AbbVie Business Overview
- 10.1.5 AbbVie SWOT Analysis
- 10.1.6 AbbVie Recent Developments
- 10.2 Alkermes
- 10.2.1 Alkermes Basic Information
- 10.2.2 Alkermes Cannabis Use Disorder Treatment Product Overview
- 10.2.3 Alkermes Cannabis Use Disorder Treatment Product Market Performance
- 10.2.4 Alkermes Business Overview
- 10.2.5 Alkermes SWOT Analysis
- 10.2.6 Alkermes Recent Developments
- 10.3 BioCorRx
- 10.3.1 BioCorRx Basic Information
- 10.3.2 BioCorRx Cannabis Use Disorder Treatment Product Overview
- 10.3.3 BioCorRx Cannabis Use Disorder Treatment Product Market Performance
- 10.3.4 BioCorRx Business Overview
- 10.3.5 BioCorRx SWOT Analysis
- 10.3.6 BioCorRx Recent Developments
- 10.4 Cipla Limited
- 10.4.1 Cipla Limited Basic Information
- 10.4.2 Cipla Limited Cannabis Use Disorder Treatment Product Overview
- 10.4.3 Cipla Limited Cannabis Use Disorder Treatment Product Market Performance
- 10.4.4 Cipla Limited Business Overview
- 10.4.5 Cipla Limited Recent Developments
- 10.5 Dr. Reddy’s Laboratories
- 10.5.1 Dr. Reddy’s Laboratories Basic Information
- 10.5.2 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product Overview
- 10.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product Market Performance
- 10.5.4 Dr. Reddy’s Laboratories Business Overview
- 10.5.5 Dr. Reddy’s Laboratories Recent Developments
- 10.6 Glenmark Pharmaceuticals Limited
- 10.6.1 Glenmark Pharmaceuticals Limited Basic Information
- 10.6.2 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Overview
- 10.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Market Performance
- 10.6.4 Glenmark Pharmaceuticals Limited Business Overview
- 10.6.5 Glenmark Pharmaceuticals Limited Recent Developments
- 10.7 Intas Pharmaceuticals Limited
- 10.7.1 Intas Pharmaceuticals Limited Basic Information
- 10.7.2 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Overview
- 10.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product Market Performance
- 10.7.4 Intas Pharmaceuticals Limited Business Overview
- 10.7.5 Intas Pharmaceuticals Limited Recent Developments
- 10.8 Indivior
- 10.8.1 Indivior Basic Information
- 10.8.2 Indivior Cannabis Use Disorder Treatment Product Overview
- 10.8.3 Indivior Cannabis Use Disorder Treatment Product Market Performance
- 10.8.4 Indivior Business Overview
- 10.8.5 Indivior Recent Developments
- 10.9 Mallinckrodt
- 10.9.1 Mallinckrodt Basic Information
- 10.9.2 Mallinckrodt Cannabis Use Disorder Treatment Product Overview
- 10.9.3 Mallinckrodt Cannabis Use Disorder Treatment Product Market Performance
- 10.9.4 Mallinckrodt Business Overview
- 10.9.5 Mallinckrodt Recent Developments
- 10.10 Noramco
- 10.10.1 Noramco Basic Information
- 10.10.2 Noramco Cannabis Use Disorder Treatment Product Overview
- 10.10.3 Noramco Cannabis Use Disorder Treatment Product Market Performance
- 10.10.4 Noramco Business Overview
- 10.10.5 Noramco Recent Developments
- 10.11 Orexo AB
- 10.11.1 Orexo AB Basic Information
- 10.11.2 Orexo AB Cannabis Use Disorder Treatment Product Overview
- 10.11.3 Orexo AB Cannabis Use Disorder Treatment Product Market Performance
- 10.11.4 Orexo AB Business Overview
- 10.11.5 Orexo AB Recent Developments
- 10.12 Purdue Pharma
- 10.12.1 Purdue Pharma Basic Information
- 10.12.2 Purdue Pharma Cannabis Use Disorder Treatment Product Overview
- 10.12.3 Purdue Pharma Cannabis Use Disorder Treatment Product Market Performance
- 10.12.4 Purdue Pharma Business Overview
- 10.12.5 Purdue Pharma Recent Developments
- 11 Cannabis Use Disorder Treatment Market Forecast by Region
- 11.1 Global Cannabis Use Disorder Treatment Market Size Forecast
- 11.2 Global Cannabis Use Disorder Treatment Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Cannabis Use Disorder Treatment Market Size Forecast by Country
- 11.2.3 Asia Pacific Cannabis Use Disorder Treatment Market Size Forecast by Region
- 11.2.4 South America Cannabis Use Disorder Treatment Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Cannabis Use Disorder Treatment by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Cannabis Use Disorder Treatment Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Cannabis Use Disorder Treatment by Type (2026-2033)
- 12.1.2 Global Cannabis Use Disorder Treatment Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Cannabis Use Disorder Treatment by Type (2026-2033)
- 12.2 Global Cannabis Use Disorder Treatment Market Forecast by Application (2026-2033)
- 12.2.1 Global Cannabis Use Disorder Treatment Sales (K Units) Forecast by Application
- 12.2.2 Global Cannabis Use Disorder Treatment Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
